Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 4/20 | 0.69 |
| ▸ | VDR | P11473 | 4/20 | 0.69 |
| ▸ | MEN1 | O00255 | 3/20 | 0.69 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.69 |
| ▸ | ADORA3 | P0DMS8 | 3/20 | 0.69 |
| ▸ | CDC25A | P30304 | 3/20 | 0.69 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.69 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.69 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.69 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.69 |
| ▸ | PGR | P06401 | 2/20 | 0.69 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.69 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.69 |
| ▸ | HPGD | P15428 | 1/20 | 0.69 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.69 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.69 |
| ▸ | GLRA1 | P23415 | 1/20 | 0.69 |
| ▸ | DRD3 | P35462 | 1/20 | 0.69 |
| ▸ | HSPE1 | P61604 | 1/20 | 0.69 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.69 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6842113 | 1.00 | MAPT (0.69) | MAPTVDRMEN1KMT2AADORA3 | |
| SCHEMBL10034118 | 1.00 | MAPT (0.69) | MAPTVDRMEN1KMT2AADORA3 | |
| SCHEMBL3698818 | 1.00 | MAPT (0.69) | MAPTVDRMEN1KMT2AADORA3 | |
| Acetic Acid SCHEMBL5184154 | 0.96 | MAPT (0.64) | MAPTVDRMEN1KMT2AADORA3 | |
| SCHEMBL233428 | 0.93 | MAPT (0.69) | MAPTVDRMEN1KMT2AADORA3 | |
| SCHEMBL10594420 | 0.91 | VDR (0.57) | MAPTVDRMEN1KMT2AADORA3 | |
| SCHEMBL4960177 | 0.89 | MAPT (0.74) | MAPTVDRMEN1KMT2AADORA3 | |
| SCHEMBL8003899 | 0.89 | MAPT (0.74) | MAPTVDRMEN1KMT2AADORA3 | |
| SCHEMBL232217 | 0.89 | MAPT (0.74) | MAPTVDRMEN1KMT2AADORA3 | |
| SCHEMBL10034122 | 0.89 | MAPT (0.74) | MAPTVDRMEN1KMT2AADORA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2527 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260116861-A1 | ISOXAZOLE HYDROXAMIC ACIDS AS HISTONE DEACETYLASE 6 INHIBITORS | THE GEORGE WASHINGTON UNIVERSITY, A CONGRESSIONALLY CHARTERED NOT-FOR-PROFIT CORPORATION (US) | 2026-04-30 | — | — | US | claimed |
| US-12522572-B2 | Isoxazole hydroxamic acids as histone deacetylase 6 inhibitors | THE GEORGE WASHINGTON UNIVERSITY, A CONGRESSIONALLY CHARTERED NOT-FOR-PROFIT CORPORATION (US) | 2026-01-13 | — | — | US | claimed |
| WO-2025108575-A1 | METHODS OF SELECTIVE DEPROTECTION AND SYNTHESIS OF TRANSHYDRINDANE- SKELETON-BASED COMPOUNDS | ROCHE DIAGNOSTICS GMBH (DE) | 2025-05-30 | — | — | WO | claimed |
| WO-2025058988-A1 | METHOD OF TREATING NON-IMMUNOGENIC SKIN CANCERS | THE GENERAL HOSPITAL CORPORATION (US) | 2025-03-20 | — | — | WO | claimed |
| WO-2024227063-A1 | METHODS AND COMPOSITIONS FOR TREATING OBESITY, SKIN DISORDERS, AND/OR EYE DISORDERS | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2024-10-31 | — | — | WO | claimed |
| US-20240343697-A1 | ISOXAZOLE HYDROXAMIC ACIDS AS HISTONE DEACETYLASE 6 INHIBITORS | THE GEORGE WASHINGTON UNIVERSITY, A CONGRESSIONALLY CHARTERED NOT-FOR-PROFIT CORPORATION (US) | 2024-10-17 | — | — | US | claimed |
| CN-111480080-B | Method for improving therapeutic cell quality by real-time glutathione measurement | 塞尔吐温株式会社 | 2023-09-19 | — | — | CN | claimed |
| US-20230242480-A1 | Alkyne Compound, Vitamin D Compound, Analytical Method, and Production Method | JEOL LTD. (JP) | 2023-08-03 | — | — | US | claimed |
| EP-4212498-A2 | ALKYNE COMPOUND, VITAMIN D COMPOUND, ANALYTICAL METHOD, AND PRODUCTION METHOD | Tokyo University of Agriculture and Technology (JP) | 2023-07-19 | — | — | EP | claimed |
| CN-116425661-A | Alkyne compounds, vitamin D compounds, analytical methods and manufacturing methods | 国立大学法人东京农工大学 | 2023-07-14 | — | — | CN | claimed |
| EP-0588539-B1 | Stabilized pharmaceutical compositions containing derivatives of vitamins D2 and D3 | TEVA PHARMA (IL) | 1997-02-05 | — | — | EP | claimed |
| WO-1996036340-A1 | STABLE AQUEOUS FORMULATIONS OF 1α,25-DIHYDROXYCHOLECALCIFEROL FOR PARENTERAL ADMINISTRATION | ABBOTT LABORATORIES (US) | 1996-11-21 | — | — | WO | claimed |
| EP-0437225-B1 | Topical preparations | HOFFMANN LA ROCHE (CH) | 1994-04-20 | — | — | EP | claimed |
| EP-0477270-A1 | PREVENTION AND TREATMENT OF MICROBIAL INFECTION BY PHOSPHOGLYCERIDES | MED-TAL, INC. (US) | 1992-04-01 | — | — | EP | claimed |
| WO-1990015609-A1 | PREVENTION AND TREATMENT OF MICROBIAL INFECTION BY PHOSPHOGLYCERIDES | MED-TAL, INC. (US) | 1990-12-27 | — | — | WO | claimed |
| EP-0313703-A1 | Use of 24,25-dihydroxycholecalciferole in the treatment of urinary calculus | KUREHA KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 1989-05-03 | — | — | EP | claimed |
| EP-0301167-A1 | A combination of cholecalciferol derivatives for the treatment of renal bone disease | Teva Pharmaceutical Industries Limited (IL) | 1989-02-01 | — | — | EP | claimed |
| EP-0230600-A1 | Production of cholecalciferol derivatives and novel intermediates used therefor | Teva Pharmaceutical Industries Limited (IL) | 1987-08-05 | — | — | EP | claimed |
| US-4617297-A | CALCIUM METABOLIC DISORDERS | HOFFMANN-LA ROCHE INC. (US) | 1986-10-14 | — | — | US | claimed |
| US-4612308-A | ANTITUMOR AND ANTILEUKEMIA AGENTS, OSTEOPOROSIS | HOFFMANN-LA ROCHE INC. (US) | 1986-09-16 | — | — | US | claimed |